Two new antibodies may treat autoimmune diseases by reducing inflammation through blocking the immune receptor FcγRI.

An international research group directed by UMC Utrecht has developed and characterized two first-in-class antibodies that ...

An international research group directed by UMC Utrecht have developed and characterized two first-in-class antibodies that ...

Global Monoclonal Antibody Therapeutics Market OverviewThe global monoclonal antibody therapeutics market is poised for substantial expansion, projected to grow at a CAGR of approximately 12% over the ...

Background Eisenmenger syndrome (ES) is a severe and fatal complication of uncorrected congenital heart disease characterised ...

Chemerin is a key adipokine that regulates lipid metabolism and insulin sensitivity, and thus is involved in many metabolic ...

In their new study, the LJI scientists are the first to show that GPR25 is induced by a signaling molecule called TGF-β.

About a year ago, a test revealed that I had an 8-mm stone in my kidney. My kidney doctor was not worried about it. I have ...

Nuvig Therapeutics, Inc., ("Nuvig") a privately held biotechnology company developing novel immunomodulatory therapeutics for patients with inflammatory autoimmune diseases, today announced the ...

This important study presents a technically rigorous and carefully controlled analysis of the signalling potential of cancer-associated gain-of-function Notch alleles. The work is clearly presented, ...

The identification of 20 causal plasma proteins for prostate cancer represents a critical step toward addressing the need for improved diagnostic specificity and reveals promising new targets for ...